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A gene for deaf ears?
Genetic mutations that lead to hearing losses have been
identified in both human and mouse populations; the gene
products include members of a class of unconventional myosins.
Pay attention only to the way in which the inner ear is
constructed, and what you find immediately suggests that
there are many potential causes of hereditary deafness.
Detection of sound is possible because the cochlea con-
tains specialized mechano-transducing cells, hair cells,
which derive their name from the stereocilia which pro-
ject from the apical surface. There is, however, no rea-
son to suspect that hair cells represent the only fragile
link in hearing, and there are now a number of genetic
links to deafness in the cochlea in both human and
mouse auditory systems [1].
PAX3 gene on chromosome 2 [3,4]. The product of this
gene is a DNA-binding protein responsible for the con-
trol of gene expression at an early stage of development; a
PAX3 mutation, therefore, compromises cochlear mor-
phogenesis. Indeed, in those patients where there is little
vestibular function, the inner-ear compartments often fail
Structurally, the cochlea is a three-dimensional device
which mechanically separates out frequency components
from a complex sound stimulus. Not only does sound
have to be delivered correctly to the cochlea via the
middle ear, but it also has to produce the correct vibra-
tion pattern in the basilar and tectorial membranes of the
cochlear partition. We also now know that the mam-
malian cochlea employs amplification processes to boost
the incoming sound [2], and that the gain has to be set
critically. Hence, small alterations in the structure or
function of a component could lead to 40 decibel
(equivalent to 100-fold) changes in hearing thresholds or
more - a substantial hearing loss. Consequently, defects
could arise through changes to the cochlea during devel-
opment, through altered function of the epithelia and
mature structures of the cochlea, or through specific
lesions to the hair cells (Fig. 1).
The sequence of steps in cochlear development is not
known with any certainty, and the genetics and molecular
biology of the auditory system, unlike that of the visual
system where the genetic determinants of colour vision
have been traced to molecular scales, are still relatively
immature. In part this is because the amounts of material
available for study are small, but it also arises because of the
relatively greater difficulty of detecting hearing losses and
of being able to identify the precise target of the mutation.
There are well over twenty known distinct hereditary
deafnesses in humans [1]. Some of the hearing losses
present variably in association with a larger set of dis-
orders, and are described as syndromic. One of these,
Waardenburg's syndrome, has been the object of con-
siderable attention. Subjects presenting this form of deaf-
ness show variable degrees of hearing losses, pigmentary
disturbances and a recognizable flattening of the facial
features (dystopia canthorum). Waardenburg syndrome
type 1 has recently been associated with a mutation of the
Fig. 1. Cross section of the mammalian cochlear duct (the organ
of Corti is enlarged) showing possible targets of genetic muta-
tions leading to hearing losses: hair cells (pink); tectorial mem-
brane (light blue), which contains collagens and tectorins [5];
non-sensory cells of the organ of Corti (yellow); basilar mem-
brane (lilac), which establishes cochlear mechanics; stria vascu-
laris (orange), which maintains endocochlear potential; cochlear
morphogenesis - for example, development of the embedding
bone (light grey).
© Current Biology 1995, Vol 5 No 7716
HEARING
DISPATCH 717
to close correctly. This may prevent the formation of the
correct ionic environment for the sensory cells within
the mature cochlea.
Non-syndromic hearing losses, not necessarily associated
with other readily identifiable features, stand a better
chance of pointing to a cochlea-specific gene defect.
They are harder to identify because the locus may be
masked by variability, but some types of deafness have
been identified in human populations because the fami-
lies are sufficiently extended and good records exist.
Recent progress has been made in mapping a progressive
hearing loss to chromosome 5q in one family and a
recessive deafness to chromosome 13q in another,
although the candidate genes have yet to be identified.
Easier to explore are hearing losses that are X-linked. Of
these, Alport's syndrome, which is a hereditary deafness
associated with kidney pathology, has received much
attention because there is a candidate gene. The gene is
linked to a site on chromosome Xq22 where nearby
deletions cause defects in type IV collagen, a collagen
that is found in kidney basement membranes. In addition
to Alport's syndrome, there is evidence that some forms
of sensori-neural hearing loss may be associated with col-
lagen deficits - particularly of types I, II, IV and XI.
These 'structural' deficits also seem attractive because
some of the key structures within the mammalian
cochlea, in particular the tectorial membrane and the
basilar membrane [5], involve collagen filaments.
USH1B mapping to chromosome llq. Weil et al. [7]
have now provided evidence that this gene encodes a
previously characterized sequence of 31 residues that was
classified as myosin VIIA.
Mice that are homozygous for mutations of the gene sh 1
are characterized by disorders in functional hearing and
balance, although there is no significant degeneration of
cochlear structure. The shl gene maps to mouse chro-
mosome 7 and appears to be homologous either to
USHB1 or to DFNB2, a human neurosensory deafness
gene, which is not associated with retinal degeneration.
Gibson et al. [8] have now shown that the mouse gene
sh also encodes the head domain of a type VII myosin.
In the three mutant forms of shl studied to date, all had
mutations that might be expected to lead to defects in
the myosin head group.
A more direct approach to identifying inner-ear-specific
proteins surprisingly yielded a collagen as the gene prod-
uct [6]. Differential screening of a cDNA library prepared
from sunfish sacculus produced a cDNA encoding a col-
lagen with extensive homology to collagen types VIII
and X, both members of short-chain collagen families. In
situ hybridization studies suggest that the collagens are
being produced by the supporting cells and that the final
target is the overlying otolithic membrane, the equivalent
of the tectorial membrane in the cochlea, which couples
the displacement stimulus to the stereocilia.
Despite being able to offer more tissue, the teleost saccu-
lus differs significantly from the mammalian cochlea, and
the pursuit of a gene product more closely related to
hair-cell function seems desirable. Two recent reports
[7,8] identify such a gene in human populations with
Usher syndrome type 1B, and in a mouse homologue,
shaker-1 (sh 1), which encodes a myosin.
Usher's syndrome patients exhibit hearing loss, distur-
bance of vestibular function and retinitis pigmentosa. In
type I syndrome, the retinitis pigmentosa has early onset
and the pathology is often associated with microtubular
disorganization and with degeneration of the cochlea. It
is known that a single gene is not responsible for the full
expression of the syndrome (at least seven genes are
implicated in the human populations), but 75 % of the
patients exhibiting the syndrome possess a defective gene
Fig. 2. Hair cell structure. Actin-filled stereocilia project from the
apical end and are displaced by the stimulus. Myosin immuno-
reactivity is reported in hair cells on and below the stereocilia
and below the nucleus. Inset shows tip-links between stereo-
cilia. The tip-links, it is proposed [10], gate the mechano-
electrical transducer channels in the membrane and are
retensioned by a cluster of myosin molecules which continuously
slide up along the actin core of the stereocilia.
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Although myosins first appeared as the motor molecules
in muscle, the family is extensive [9]. It contains classes
which depend for their classification not only on the tail,
but also on sequence differences in the head group. The
myosin class VII is one of the so-called 'unconventional'
myosins; myosins of class VII have been found in a pig
kidney cell line and in Drosophila, but as yet no represen-
tative of this class has been functionally characterized.
Myosins made their appearance in the hair-cell literature
over a decade ago, and were initially implicated in the
process of sound amplification in the cochlea. This idea
is currently not in vogue, and other mechanisms of
amplification are thought to be employed [2].
There is, however, evidence that a short-tail myosin,
myosin 1, may be involved in the first steps of
mechano-transduction in hair cells, at least in the hair
cells found in the frog sacculus. Mechano-electrical
transduction in all hair cells involves deflection of the
stereocilia (Fig. 2). When the stereocilia are deflected, it
is believed that transducer channels near the stereocilial
tips are gated open. The molecular identity of the cou-
pling between stereocilial deflection and transducer chan-
nel is not known [10], but the favoured mechanism
employs a connection between the stereocilia, a 'tip link',
which transfers energy to the ion channel for gating. The
efficiency of this mechanism depends on tension being
maintained in the link. The tensioning mechanism, it is
proposed, uses myosin motors which pull the link tight.
There is evidence that this tensioning process, or adapta-
tion motor, depends on myosin 1 [11,12]. The con-
clusion depends on the identification of 13 different
myosins, the products of 10 different genes, expressed in
hair cells and supporting cells of the bullfrog saccular
macula [11]. Antibodies raised against myosin 1 label
the tips of the hair-cell stereocilia, and the identified
myosin contains ATP- and calmodulin-binding sites, for
both of which there is physiological support.
Myosin VII and myosin 13 are not, however, the same.
The appearance of myosins associated with auditory
transduction in two different contexts may be fortuitous,
and it has yet to be shown that the product of the sh 1
gene is associated with the hair cells (although a rat
outer-hair-cell cDNA library is reported to include an
appropriately sized product [8]). It might be the case that
different myosins are employed for the adaptation motor
in mammals, distinct from those of frog inner-ear systems.
Alternatively, it could be that shl and the USHIB gene
on chromosome 11 encode a myosin involved in 'house-
keeping' operations in cells of the cochlea, such as vesicle
transport or microvillous organization, as suggested by
the extensive microtubular structures near the apical
membrane of hair cells. Clearly, there are further localiza-
tion and gene-knockout experiments to be performed,
and such experiments are possible now that the mouse
models have been established. Nevertheless, the identi-
fication of a motor protein as the gene product of
shl/USHIB takes us one step forward to understanding
and, perhaps, preventing hearing losses.
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